Dual-responsive nanosystem for precise molecular subtyping and resistant reversal of EGFR targeted therapy
Sign Up to like & getrecommendations! Published in 2019 at "Chemical Engineering Journal"
DOI: 10.1016/j.cej.2019.04.140
Abstract: Abstract The clinical outcome of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors is limited by the ambiguous molecular subtypes of non-small cell lung cancer (NSCLC) patients and the emergence of drug-resistance. Here, a nanotheranostic… read more here.
Keywords: responsive nanosystem; egfr; mutated nsclc; dual responsive ... See more keywords